Viewing StudyNCT00253227



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00253227
Status: COMPLETED
Last Update Posted: 2011-05-18
First Post: 2005-11-10

Brief Title: A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimers Disease
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Dementia
Alzheimer Disease
Keywords:
Name View
placebo View
Alzheimers disease View
dementia View
brain disease View
memory loss View
galantamine View